促销时间表 Genelux Corporation
先进的时间表
简单图表
关于公司 Genelux Corporation
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. 更多详情| IPO date | 2023-01-26 |
|---|---|
| ISIN | US36870H1032 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.genelux.com |
| Цена ао | 4.56 |
| 每日价格变化: | -3.02% (4.31) |
|---|---|
| 每周价格变化: | -13.1% (4.81) |
| 每月价格变化: | +2.45% (4.08) |
| 3个月内价格变化: | +55.39% (2.69) |
| 六个月内的价格变化: | +100.96% (2.08) |
| 每年价格变化: | -42.5% (7.27) |
| 3年内价格变化: | 0% (4.18) |
| 5年内价格变化: | 0% (4.18) |
| 10年价格变化: | 0% (4.18) |
| 年初以来价格变化: | +81.74% (2.3) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Blackrock Inc. | 1196123 | 4.48 |
| Vanguard Group Inc | 980993 | 3.67 |
| Geode Capital Management, LLC | 386634 | 1.45 |
| State Street Corporation | 231065 | 0.86 |
| AE Wealth Management LLC | 194875 | 0.73 |
| Northern Trust Corporation | 160816 | 0.6 |
| Provident Wealth Management, LLC | 157137 | 0.59 |
| Charles Schwab Investment Management, Inc. | 149604 | 0.56 |
| Bank Of New York Mellon Corporation | 53841 | 0.2 |
| AMG National Trust Bank | 50346 | 0.19 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| Range Cancer Therapeutics ETF | 0.53743 | 47.24 | 0.11955 |
| iShares Micro-Cap ETF | 0.01521 | 17.09 | 1.54048 |
Schwab U.S. Small-Cap ETF
|
0.0013 | 17.47 | 1.51433 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Thomas Zindrick J.D. | Chairman, CEO & President | 570.99k | 1959 (66 年) |
| Mr. Sean Ryder J.D. | General Counsel & Corporate Secretary | 380k | 1969 (56 年) |
| Ms. Lourie S. Zak | Chief Financial Officer | 346.19k | 1963 (62 年) |
| Dr. Joseph Cappello Ph.D. | Chief Technical Officer | 213.08k | 1957 (68 年) |
| Dr. Yong Yu Ph.D. | Senior Vice President of Clinical Development | 242.62k | 1971 (54 年) |
| Prof. Paul Scigalla M.D., Ph.D. | Chief Medical Officer | N/A | 1945 (80 年) |
| Mr. Ralph Smalling B.Sc. | VP & Head of Regulatory Affairs | N/A | 1957 (68 年) |
| Ms. Caroline Jewett | VP & Head of Quality | 269.26k | 1965 (60 年) |
地址: United States, Westlake Village. CA, 2625 Townsgate Road - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.genelux.com
网站: https://www.genelux.com
